Cingulate INC 8-K filings

NASDAQ

13 Feb 2024

CING

8-K: Cingulate Inc. Appoints Three New Directors Following Successful Capital Raise

Cingulate Inc. has appointed three new independent directors to its board, following a recent public offering and other capital raising activities.

NASDAQ

6 Feb 2024

CING

Cingulate INC

8-K: Cingulate Inc. Secures $7.5 Million in Public Offering to Advance Drug Pipeline

Cingulate Inc. has successfully priced and closed a public offering, raising $7.5 million to support the development and commercialization of its pharmaceutical products.

NASDAQ

29 Jan 2024

CING

Cingulate INC

8-K: Cingulate Inc. Converts $3.3 Million Debt to Equity, Appoints New CFO

Cingulate Inc. has converted $3.3 million of debt and accrued interest into equity and appointed Jennifer Callahan as its new Chief Financial Officer.